Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
University Of New Brunswick currently manages 2 pending office actions within the Biotechnology and Pharmaceuticals technology area. These 2 pending office actions are distributed across 2 distinct examiners. Furthermore, the prosecution is taking place in 2 distinct art units. The presence of 2 distinct art units indicates that the company's applications are being reviewed in different technical departments at the USPTO. This requires a strategy that can adapt to the specific requirements of 2 distinct art units.
The busiest examiner for the portfolio is CHICKS, ASHLI ARIANA, who is assigned 1 busiest examiner pending office action. This 1 busiest examiner pending action is less than the total of 2 pending office actions for the company. Because there are 2 distinct examiners involved, the applicant must manage interactions with different individuals. The 2 pending office actions in the Biotechnology and Pharmaceuticals area show the current scope of the company's active prosecution. Having 2 distinct examiners and 2 distinct art units means the feedback received may vary across the different cases.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHICKS, ASHLI ARIANA | 1 | 59.4% | +51.7% |
| MENON, KRISHNAN S | 1 | 59.7% | +11.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16444939 | TRANSITIONAL METAL OXIDE NANOCRYSTAL-COATED MESOPOROUS MICROSTRUCTURES, USES THEREFOR, AND PROCESSES FOR MAKING SAME | MENON, KRISHNAN S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17911302 | COMPOSITIONS, METHODS AND USES OF COMBINATION TREATMENTS FOR BLOOD CANCERS | CHICKS, ASHLI ARIANA | 83d |
| 16444939 | TRANSITIONAL METAL OXIDE NANOCRYSTAL-COATED MESOPOROUS MICROSTRUCTURES, USES THEREFOR, AND PROCESSES FOR MAKING SAME | MENON, KRISHNAN S | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1777 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17911302 | COMPOSITIONS, METHODS AND USES OF COMBINATION TREATMENTS FOR BLOOD CANCERS | CHICKS, ASHLI ARIANA | 1626 | §103§112DP | Non-Final OA | 83d | Pending | Sep 13, 2022 |
| 16444939 | TRANSITIONAL METAL OXIDE NANOCRYSTAL-COATED MESOPOROUS MICROSTRUCTURES, USES THEREFOR, AND PROCESSES FOR MAKING SAME | MENON, KRISHNAN S | 1777 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity Of New Brunswick has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Ashli Ariana Chicks has the most, with 1 of University Of New Brunswick's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.